More articles about: All Research Topics

Ethan White was diagnosed with diffuse midline glioma, a rare form of brain cancer where the survival time after diagnosis is 1-2 years. His treatment is going well and Koschmann is cautiously optimistic about his case.

Research by the University of Michigan Health Rogel Cancer Center finds that patients with three of these variants face no extra risk of dying from their cancer.

Researchers at the Rogel Cancer Center, in collaboration with Arcascope, have developed and tested a personalized app that tracks a user’s circadian rhythm and makes behavioral recommendations to reduce daily fatigue.

Medicare and most private insurance plans don’t cover anti-obesity medications like Wegovy (also sold as Ozempic), but a new poll of older adults shows widespread support and interest in using them.

Stroke survivors who have attended some level of higher education may face even steeper mental declines, according to a study led by Michigan Medicine.

University of Michigan research reveals that simple awareness from the hospital care team can help protect a breastfeeding relationship for patients in the ICU and their newborn baby.

A study from University of Michigan researchers has uncovered the mechanism behind the arms race for mouse X and Y bearing sperm to fertilize an egg.

University of Michigan researchers show that using continuous glucose monitors can help measure glucose accurately during DKA and potentially prevent ICUs from being overwhelmed.

Michigan Medicine experts discuss CAR T therapy, its use in other clinical trials at U-M and the new Phase I trials that started in March 2025.

A large genome wide association study (GWAS) of psoriasis identifies new susceptibility variants that underlie this common, yet enigmatic, skin disease.

Avapritinib, an FDA-approved drug used to treat other types of cancer, also decreases aggressive gliomas in animal models and in an initial cohort of patients with high-grade glioma.

A young man from Michigan who was born with the rare disease Barth Syndrome received a new heart over two decades after having a heart transplant as an infant.

Patients receiving radiation treatment for cancer from around the country now benefit from a University of Michigan-developed code that research clinicians developed.

Michigan Medicine becomes leader in treating severe ulcerative colitis with JAK inhibitors.

A study demonstrates how histotripsy could stimulate the immune system to destroy a cancer through the release of tumor antigens.